✦ LIBER ✦

Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: A novel histamine H4 receptor antagonist

✍ Scribed by Charles E. Mowbray; Andrew S. Bell; Nicholas P. Clarke; Michelle Collins; Rhys M. Jones; Charlotte A.L. Lane; Wai L. Liu; Sandra D. Newman; Michael Paradowski; Emanuel J. Schenck; Mathew D. Selby; Nigel A. Swain; David H. Williams

Book ID: 113496044
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 487 KB
Volume: 21
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2011.07.125

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Challenges of Drug

ChemInform Abstract: Challenges of Drug Discovery in Novel Target Space. The Discovery and Evaluation of PF-3893787 (I): A Novel Histamine H4 Receptor Antagonist.

✍ Charles E. Mowbray; et al. et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 19 KB 👁 2 views

Discovery of a Novel Superpotent and Sel

Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo 1

✍ Kask, Ants; Mutulis, Felikss; Muceniece, Ruta; Pähkla, Rein; Mutule, Ilze; Wikbe 📂 Article 📅 1998 🏛 Endocrine Society 🌐 English ⚖ 229 KB

Discovery of 2-(2-Chlorophenyl)-3-(4-chl

Discovery of 2-(2-Chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2 H -pyrazolo[3,4- f ][1,4]oxazepin-8(5 H )-one (PF-514273), a Novel, Bicyclic Lactam-Based Cannabinoid-1 Receptor Antagonist for the Treatment of Obesity

✍ Dow, Robert L.; Carpino, Philip A.; Hadcock, John R.; Black, Shawn C.; Iredale, 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 191 KB

Mutagenic evaluation of etintidine (BL-5

Mutagenic evaluation of etintidine (BL-5641), a novel histamine H2-receptor antagonist, using the chromosome aberration test in CHL cells and the micronucleus test in mice

✍ Fumiaki Ishida; Toshio Kamei 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Discovery of a Novel Class of Phosphodie

Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia † † Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).

✍ Verhoest, Patrick R.; Chapin, Douglas S.; Corman, Michael; Fonseca, Kari; Harms, 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 1015 KB